Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-21,955
Closed -$700K 48
2017
Q2
$700K Sell
21,955
-4,954
-18% -$156K 0.53% 30
2017
Q1
$873K Sell
26,909
-5,270
-16% -$166K 0.55% 39
2016
Q4
$992K Hold
32,179
0.6% 36
2016
Q3
$1.03M Buy
32,179
+11,608
+56% +$388K 0.58% 39
2016
Q2
$687K Hold
20,571
0.41% 42
2016
Q1
$578K Sell
20,571
-3
-0% -$86 0.31% 41
2015
Q4
$630K Sell
20,574
-315
-2% -$9.91K 0.33% 45
2015
Q3
$623K Sell
20,889
-1,803
-8% -$57.8K 0.31% 45
2015
Q2
$722K Hold
22,692
0.34% 44
2015
Q1
$749K Sell
22,692
-254
-1% -$8.07K 0.36% 47
2014
Q4
$678K Hold
22,946
0.32% 47
2014
Q3
$644K Sell
22,946
-1,760
-7% -$49.4K 0.29% 46
2014
Q2
$696K Sell
24,706
-632
-2% -$18K 0.32% 49
2014
Q1
$772K Sell
25,338
-1,001
-4% -$29.8K 0.32% 50
2013
Q4
$765K Sell
26,339
-422
-2% -$12.3K 0.31% 51
2013
Q3
$729K Sell
26,761
-3,499
-12% -$95.2K 0.29% 53
2013
Q2
$804K Buy
+30,260
New +$836K 0.36% 55

Other funds holding PFE

FCM Investments's PFE Position: Q3 2017 in Review

FCM Investments sold out of Pfizer (PFE) in Q3 2017, closing a stake of 21,955 shares — an estimated $700K sold.

FCM Investments first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $1.03M in Q3 2016. 2,041 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • FCM Investments reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • FCM Investments sold 21,955 Pfizer shares in Q3 2017, an estimated $700K.
  • FCM Investments first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
  • FCM Investments's Pfizer position peaked at $1.03M in Q3 2016.
  • 2,041 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on FCM Investments's 13F filing for Q3 2017, filed 17 Oct 2017.